The road to the AI Act: the Italian approach - Part 1: the Italian[...]
Acting against unknown hackers: a groundbreaking Australian data breach[...]
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15[...]
05/16/2022 | Press release | Distributed by Public on 05/17/2022 10:52
Vicarious Surgical reaffirmed that it would not be making an FDA submission for its surgical robot until 2024.
Please select the service you want to use:
Smartlinks | Vicarious Surgical Inc. | News | Health | Science | Research | Local News | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Public Companies | Medical Technology Companies | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact
